Arthritis & Rheumatism

FDA expands pediatric indication for Rinvoq

The U.S. Food and Drug Administration has expanded indications for AbbVie's Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic ...

Overweight & Obesity

WHO, Lilly issue warnings about fake weight-loss drugs

Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.

page 15 from 40